Lv41
778 积分 2022-04-12 加入
Refining the Role of Beta-Blockers in Cardiovascular Medicine
8小时前
待确认
1289-OR: Effect of Different Treatment Durations of Sodium–Glucose Cotransporter 2 Inhibitor on Cardiovascular Outcomes in Patients with Type 2 Diabetes: A Target Trial Emulation Study
9天前
已关闭
Impact of empagliflozin on serum calcium and phosphate in heart failure
16天前
已完结
Comparative effectiveness of dapagliflozin vs . empagliflozin on major adverse cardiovascular events in patients with heart failure with reduced ejection fraction: A real‐world prospective cohort study
16天前
已完结
Dapagliflozin preserves kidney function and reduces albuminuria in children with chronic kidney disease
16天前
已完结
Are SGLT2 inhibitors really associated with increased urinary tract infection risk? A trial-level meta-analysis across type 2 diabetes, heart failure, and chronic kidney disease
16天前
已完结
Valproate in the treatment of epilepsy in girls and women of childbearing potential
1个月前
已完结
Extended‐release antiepileptic drugs: A comparison of pharmacokinetic parameters relative to original immediate‐release formulations
1个月前
已完结
Efficacy and safety of empagliflozin as add-on to metformin for type 2 diabetes: a systematic review and meta-analysis
1个月前
已完结
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
1个月前
已完结
皖公网安备34019202002308
